|
EIF4EBP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.187600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.713400E-01 |
| Normal-vs-Stage2 |
1.539050E-01 |
| Normal-vs-Stage3 |
4.939100E-03 |
| Normal-vs-Stage4 |
1.337740E-02 |
| Stage1-vs-Stage2 |
2.549400E-01 |
| Stage1-vs-Stage3 |
1.144480E-02 |
| Stage1-vs-Stage4 |
1.997810E-02 |
| Stage2-vs-Stage3 |
4.500600E-01 |
| Stage2-vs-Stage4 |
4.070600E-01 |
| Stage3-vs-Stage4 |
8.759800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.463800E-02 |
| Normal-vs-AfricanAmerican |
8.794000E-01 |
| Normal-vs-Asian |
1.251220E-01 |
| Caucasian-vs-AfricanAmerican |
4.848600E-01 |
| Caucasian-vs-Asian |
5.145000E-01 |
| AfricanAmerican-vs-Asian |
3.406200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.514400E-02 |
| Normal-vs-Female |
7.860400E-02 |
| Male-vs-Female |
4.734600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.511400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.068500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.760400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.701200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.077190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.113170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.240200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.295200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.365600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.271600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.540100E-02 |
| Classical-VS-Follicular |
2.939600E-02 |
| Classical-VS-Other |
4.062200E-01 |
| Classical-VS-Normal |
5.384600E-01 |
| Tall-VS-Follicular |
9.794200E-01 |
| Tall-VS-Other |
9.567200E-01 |
| Tall-VS-Normal |
6.274300E-02 |
| Follicular-VS-Other |
9.723000E-01 |
| Follicular-VS-Normal |
2.066500E-02 |
| Other-VS-Normal |
2.115600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.819600E-02 |
| Normal-vs-N1 |
1.322630E-01 |
| N0-vs-N1 |
9.743200E-01 |
|
|
